对于亨廷顿病胆固醇的杜特特拉贝纳的真实世界经验
Kendall Curtis1,2, Victor Sung2
1University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Journal of clinical pharmacology
|August 11, 2023
概括
杜特特拉贝纳有效地降低了亨廷顿病 (HD) 患者的胆病症状. 现实世界的数据表明,它被很好地容忍,不良事件率很低,支持其用于HD胆固醇治疗的使用.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 遗传学 遗传学 是一个
背景情况:
- 亨廷顿氏病 (HD) 是一种遗传性神经退行性疾病,其特征是霍乱.
- 目前对HD胆固醇的治疗包括四贝纳和二贝纳,这两种都是膀单胺转运体2型抑制剂.
- 相比于tetrabenazine,deutetrabenazine具有较长的半衰期和较少的剂量.
研究的目的:
- 评估Deutetrabenazine在亨廷顿病患者的胆病治疗中的实际临床经验和有效性.
- 评估deutetrabenazine在临床环境中的安全性和耐受性.
主要方法:
- 在2017年1月至2019年5月期间,58名亨廷顿病患者接受了deutetrabenazine治疗.
- 抽象的数据包括胆固醇得分,患者报告的疗效,剂量和不良事件.
- 分析治疗持续时间和胆固醇严重程度的变化.
主要成果:
- 观察到,总最大胆叶病得分的平均减少为4.4.
- 副作用的总比率为32.8%,其中镇静,失眠和腹是最常见的.
- 患者平均接受了476.4天的治疗,这表明持续使用.
结论:
- 现实世界的数据支持deutetrabenazine作为亨廷顿病相关的霍乱的有效治疗.
- 在临床实践中,deutetrabenazine显示出良好的安全性和耐受性.
- 更大的,多中心的研究是有必要的,以进一步验证这些发现在不同的人口.
相关概念视频
01:24Parkinson's Disease: Treatment
299
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
299
01:15Parkinson's Disease: Overview
598
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
598
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
791
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
791
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
332
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
332
01:26Anticholinesterase Agents: Poisoning and Treatment
921
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
921